Content in this section will include AAPM advocacy efforts, legislative news, public statements, etc.

Surgeon General Advises Hospitals to Cancel Elective Surgeries

U.S. Surgeon General VADM Jerome Adams, MD MPH, warns that every elective surgery could spread coronavirus within a medical center. The nation's top doctor on Saturday urged a widespread halt of hospital elective pr...
Continue reading
Topics:

COVID-19 Information for the Healthcare Professional

The Centers for Disease Control and Prevention (CDC) has Coronavirus Disease 2019 (COVID-19) information and resources available to health care professionals on its website. View COVID-19 information for healthcare profe...
Continue reading
Topics:

AAPM Endorses the FOVA FY 2021 Budget Recommendation

AAPM endorsed the Friends of VA Medical Care and Health Research (FOVA) FY 2021 budget recommendation of $860 million for the VA Medical and Prosthetic Research program. Full story .

FDA Approves Three Drugs for Nonprescription Use Through Rx-to-OTC Switch Process

The U.S. Food and Drug Administration today approved three drugs for nonprescription, or over-the-counter (OTC), use through a process called a prescription (Rx)-to-OTC switch. The FDA approved Voltaren Arthritis Pain (d...
Continue reading
Topics:
FDA

CMS Finalizes Decision to Cover Acupuncture for Chronic Low Back Pain for Medicare Beneficiaries

Before this final National Coverage Determination (NCD) reconsideration, acupuncture was nationally non-covered by Medicare. CMS conducted evidence reviews and examined the coverage policies of private payers to inform i...
Continue reading

Physician Office Visits at Which Benzodiazepines Were Prescribed: Findings From 2014–2016 National Ambulatory Medical Care Survey

The newly published report describes characteristics of visits to office-based physicians at which benzodiazepines were prescribed, including visits where opioids were coprescribed.

Continue reading
Topics:

FDA Alert: AXIA Pharmaceutical Issues Voluntary Nationwide Recall of All Sterile Drug Products

 AXIA Pharmaceutical is voluntarily recalling all unused sterile drug products within expiry due to a lack of assurance of sterility. The recalled sterile products have been found to be inconsistent with federal gui...
Continue reading
Topics:
FDA

Closing Gaps in Cannabinoid Research to Make Progress in Pain Management

David Shurtleff, PhD, Deputy Director at the National Center for Complementary and Integrative Health, National Institutes of Health, shares his thoughts on closing gaps in cannabinoid research to make progress in pain m...
Continue reading
Topics:

FDA Warns about Serious Breathing Problems with Seizure and Nerve Pain Medicines Gabapentin

The U.S. Food and Drug Administration is warning that serious breathing difficulties may occur in patients using gabapentin (Neurontin, Gralise, Horizant) or pregabalin (Lyrica, Lyrica CR) who have respiratory risk facto...
Continue reading
Topics:

Report from the November 2019 AMA Interim Meeting

The following report was submitted by Robert Wailes, MD, AAPM AMA Delegate The Interim Meeting of the American Medical Association (AMA) House of Delegates (HOD) convened November 16, 2019 in San Diego. I represented the...
Continue reading
Topics:
AMA

Want more pain resources? Check out our library of on-demand education, upcoming events, and more.

Learn More